13 February 2007 Novel optical spectroscopy system for breast cancer diagnostics
Author Affiliations +
We report on development of minimally invasive system for immediate diagnostics of breast cancer and on the results of its pilot clinical testing. The system designed by BioTelligent Inc is based on analysis of optical diffusion spectra (ODS) measured by a probe inserted into breast tissue during standard punch biopsy. Analysis of scattered spectra aimed to distinction of benign tumors from malignant ones is done by original procedure of data processing. Clinical testing of the created diagnostic system has been performed by classification of spectra collected from 146 patients with previously detected mammary neoplasms. The data of ODS study in each patient have been compared to the results of histology. The proposed technique has to date demonstrated sensitivity of 96%, specificity of 80% and diagnostic accuracy of 88%. These values are expected to improve as the data sets continue to grow and more sophisticated data processing is employed.
© (2007) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Natalia Shakhova, Natalia Shakhova, Ilya Turchin, Ilya Turchin, Vladislav Kamensky, Vladislav Kamensky, Ekaterina Sergeeva, Ekaterina Sergeeva, German Golubyatnikov, German Golubyatnikov, Luiz Da Silva, Luiz Da Silva, Usha Kasthuri, Usha Kasthuri, Irina Pavlycheva, Irina Pavlycheva, Svetlana Smetanina, Svetlana Smetanina, Anna Artifeksova, Anna Artifeksova, Sergey Belkov, Sergey Belkov, Gennady Kochemasov, Gennady Kochemasov, } "Novel optical spectroscopy system for breast cancer diagnostics", Proc. SPIE 6430, Advanced Biomedical and Clinical Diagnostic Systems V, 64300N (13 February 2007); doi: 10.1117/12.700656; https://doi.org/10.1117/12.700656

Back to Top